Literature DB >> 33413966

A New Ultrasonographic "Fluttering Sign" for Hepatic Hemangioma.

Natsuko Kobayashi1, Hiroko Iijima2, Toshifumi Tada3, Yoko Shibata4, Takashi Nishimura5, Takashi Kumada6, Mariko Hashimoto4, Akiko Higashiura4, Masahiro Yoshida4, Junko Nishimura4, Nobuhiro Aizawa7, Naoto Ikeda7, Tomoyuki Takashima7, Ryo Takata7, Hiroki Nishikawa7, Yoshinori Iwata7, Hirayuki Enomoto7, Seiichi Hirota8, Etsuro Hatano9.   

Abstract

The aim of the study described here was to clarify the diagnostic value of the fluttering sign, a new sign that characterizes hepatic hemangiomas in gray-scale ultrasonography (US). It refers to a phenomenon in which the speckled echogenicity inside the hemangioma changes continuously and seems to be moving. A total of 172 hemangiomas diagnosed with contrast-enhanced US were evaluated. The fluttering sign was found in 123 of 172 hemangiomas (71.5%). Its prevalence was significantly higher than that of the marginal strong echo (89/172, 51.7%, p < 0.001), posterior acoustic enhancement (103/172, 59.9%, p = 0.031) and chameleon sign (100/172, 58.1%, p = 0.013). In addition, the fluttering sign was observed significantly more frequently in mixed or hypo-echoic tumors than in hyper-echoic tumors (p < 0.001), relatively large tumors (p < 0.001) and tumors that were less than 5 cm from the body surface (p = 0.015). The fluttering sign in gray-scale US has great potential to be a new complementary sign for the diagnosis of hemangioma.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Echogenicity; Fluttering sign; Hepatic hemangioma; Speckle; Ultrasound

Year:  2021        PMID: 33413966     DOI: 10.1016/j.ultrasmedbio.2020.12.004

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  1 in total

1.  A sonographic software program, Fluctuational Imaging, for diagnosis of hepatic hemangioma.

Authors:  Hiroshi Imamura; Jiro Hata
Journal:  Sci Rep       Date:  2022-03-18       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.